J&J Appeals FDA "Not-Approvable" Letter For Sedasys Sedation System
This article was originally published in The Pink Sheet Daily
Executive Summary
Sedasys was recommended for approval, with conditions, by FDA's Anesthesiology and Respiratory Therapy Devices panel in an 8-2 vote last May, but FDA is not required to follow advisory panel recommendations.